Collaboration supports the patient journey
across the care continuum and eases transitions and care from the
hospital to home
CHICAGO and BOSTON, Feb. 26,
2024 /PRNewswire/ -- GE HealthCare (Nasdaq:
GEHC) and Biofourmis have announced a strategic collaboration
aimed at enhancing continuity of care by enabling safe, effective,
and accessible care in the home to support the patient journey
beyond the hospital setting. The collaboration leverages the
combined expertise of two market leaders to scale and deliver
innovative care-at-home solutions.
Hospital systems are experiencing increased cost of care due to
workforce shortages, constrained bed capacity and increasing
readmission rates.i,ii Care-at-home programs, which
typically include a virtual component, have proven to be effective
in decreasing the length of stay and readmission rates which can
result in the overall cost of care being reduced.iii,iv
Additionally, care-at-home programs can also support patient
recovery and safety, with a potential reduction in fall risk and
hospital acquired infectionsv Patients using remote
solutions in their homes are three times more likely to be
satisfied with the overall care experience.vi
The goal of the GE HealthCare-Biofourmis collaboration is to
enable more patients to go home earlier, and offer an alternative
to facility-based care with the comfort and peace of mind that they
are receiving high quality care at home with the intent of driving
healthy behaviors in patients by managing them remotely. Moreover,
insights from Biofourmis' FDA-cleared, AI-guided algorithms can
help care teams deliver efficient, personalized care at home.
"Biofourmis' demonstrated success with care-at-home solutions
will extend GE HealthCare's current inpatient monitoring portfolio
to support patient care from the hospital to home," said
Ashutosh Banerjee, GE HealthCare. "Combining our companies'
demonstrated capabilities will help revolutionize the way we
approach the patient care journey as well as help address current
challenges faced by health systems including hospital capacity
issues and clinical staffing shortages."
Biofourmis offers care-at-home solutions to deliver and enable
care both virtually and in person using its digital platform, with
FDA-cleared AI-guided algorithms, clinical-grade wearable devices,
in-home services orchestration technology, and nursing services.
The solutions provide numerous dynamic care pathways with
questionnaire-branching logic to provide enhanced clinical context
for care teams.
GE HealthCare's FlexAcuity™ monitoring solutions in combination
with GE HealthCare's virtual care solutions like Mural ICU, Command
Center and Digital CMU adapt to rapidly changing patient needs
in the hospital and are built on a legacy of innovation. By
offering Biofourmis' virtual care-at-home solutions to customers,
GE HealthCare can extend the care continuum beyond the hospital,
and care teams can have a longitudinal patient view beyond the
hospital setting.
Ross Armstrong, General Manager
of Biofourmis Care, said: "Our collaboration will enable health
systems and hospitals to leverage the power of technology and data
in order to shape patient-focused solutions across the care
continuum, no matter where the site of care is."
GE HealthCare will begin distributing Biofourmis solutions to
customers in the United States
starting Q1 2024.
About Biofourmis
Biofourmis delivers
technology-enabled solutions that bring the right care to any
person anywhere. Biofourmis' innovative solutions provide people
everywhere with connected access to hospital-level services,
virtual provider networks for remote care, in-home services, and
life-changing clinical trials—all without leaving their homes. The
company's FDA-cleared AI-enabled analytics collect and analyze
patient data in real time and identify shifts that can assist in
supporting proactive interventions. Trusted by leading health
systems, payers, biopharma companies and patients alike,
Biofourmis' connected platform improves patient outcomes, prevents
hospital readmissions, aims to accelerate drug development, and
closes critical gaps in care—ultimately making science smarter,
healthcare simpler, and patients healthier. Biofourmis is a global
technology company enabling care delivery, with headquarters in
Boston and offices in Singapore and India. For more information, visit
biofourmis.com and follow Biofourmis on LinkedIn.
About GE HealthCare Technologies Inc.
GE HealthCare is
a leading global medical technology, pharmaceutical diagnostics,
and digital solutions innovator, dedicated to providing integrated
solutions, services, and data analytics to make hospitals more
efficient, clinicians more effective, therapies more precise, and
patients healthier and happier. Serving patients and providers for
more than 100 years, GE HealthCare is advancing personalized,
connected, and compassionate care, while simplifying the patient's
journey across the care pathway. Together our Imaging, Ultrasound,
Patient Care Solutions, and Pharmaceutical Diagnostics businesses
help improve patient care from diagnosis, to therapy, to
monitoring. We are a $19.6 billion
business with 51,000 colleagues working to create a world where
healthcare has no limits.
Follow us on LinkedIn, Twitter, and Insights for the latest
news, or visit our website https://www.gehealthcare.com/ for
more information.
Media Contacts:
Biofourmis Media Contact:
Tara Stultz
Amendola Communications
440. 225. 9595
tstultz@acmarketingpr.com
GE HealthCare Media Contact:
Jennifer Purdue
267. 593. 9735
jennifer.purdue@gehealthcare.com
i Fleron, A., Krishna, A., & Singhal, S.
(2022, September 19). The gathering
storm: The transformative impact of inflation on the healthcare
sector. McKinsey & Company.
https://www.mckinsey.com/industries/healthcare/our-insights/the-gathering-storm-the-transformative-impact-of-inflation-on-the-healthcare-sector
ii Massive Growth in Expenses and Rising Inflation
Fuel Continued Financial Challenges for America's Hospitals and
Health Systems . American Hospital Association. (2022, April).
https://www.aha.org/system/files/media/file/2022/04/2022-Hospital-Expenses-Increase-Report-Final-Final.pdf
iii Levine DM, Ouchi K, Blanchfield B, Saenz A,
Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care
at Home for Acutely Ill Adults: A Randomized Controlled Trial.
Ann Intern Med. 2020 Jan 21;172(2):77-85. doi:
10.7326/M19-0600. Epub 2019 Dec 17. PMID: 31842232.
iv Leff B, Burton L, Mader SL, Naughton B, Burl J,
Inouye SK, Greenough WB 3rd, Guido S, Langston C, Frick KD,
Steinwachs D, Burton JR. Hospital at home: feasibility and outcomes
of a program to provide hospital-level care at home for acutely ill
older patients. Ann Intern Med. 2005 Dec 6;143(11):798-808. doi:
10.7326/0003-4819-143-11-200512060-00008. PMID: 16330791.
v Telehealth: Helping hospitals deliver
cost-effective care. American Hospital Association. (2016,
April 22).
https://www.aha.org/system/files/content/16/16telehealthissuebrief.pdf
vi Leff B, Burton L, Mader S, Naughton B, Burl J,
Clark R, Greenough WB 3rd, Guido S, Steinwachs D, Burton JR.
Satisfaction with hospital at home care. J Am Geriatr Soc.
2006 Sep;54(9):1355-63. doi: 10.1111/j.1532-5415.2006.00855.x.
PMID: 16970642.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ge-healthcare-and-biofourmis-collaborate-to-extend-patient-monitoring-outside-the-hospital-with-virtual-care-at-home-solutions-302070324.html
SOURCE Biofourmis